Kenneth Research recently added a report on ‘Non Invasive Prenatal Testing (NIPT) Market’ in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the Non Invasive Prenatal Testing (NIPT) Market, along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Fowsllowing the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Non Invasive Prenatal Testing (NIPT) Market products.
Request of this Sample Report – https://www.kennethresearch.com/sample-request-10059405
The global Non Invasive Prenatal Testing (NIPT)Marketwas valued at USD 1.28 billion in 2016 and is projected to reach USD 4.99billion by 2025, growing at a CAGR of 16.32% from 2017 to 2025.
Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS) is a new genetic test that uses cell-free circulating fetal DNA in the maternal serum to screen for the more common fetal aneuploidies and other genetic disorders.
1. Market Drivers
1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
1.2 Growing Preference for Non-Invasive Techniques Over Invasive Methods
1.3 Launch of New and Advanced Products
1.4 Improving Reimbursement Scenario for NIPT
1.5 Programs Focusing on Increasing the Awareness of NIPT
2. Market Restraints
2.1 Lack of Skilled Professionals
1. Global Non Invasive Prenatal Testing (NIPT)Market, by End User:
1.1 Diagnostic Laboratories
2. Global Non Invasive Prenatal Testing (NIPT)Market, by Application:
2.2 Microdeletion Syndrome
2.3 Other Applications
3. Global Non Invasive Prenatal Testing (NIPT)Market, by Method:
3.1 Ultrasound Detection
3.2 Biochemical Screening Tests
3.3 Cell-Free Dna in Maternal Plasma Tests
3.4 Fetal Cells in Maternal Blood Tests
4. Global Non Invasive Prenatal Testing (NIPT) Market, by Product:
4.1.1 Assay Kits & Reagents
4.2.1 Ultrasound Devices
4.2.2 Next-Generation Sequencing Systems
4.2.3 Polymerase Chain Reaction Instruments
4.2.5 Other Instruments
5. Global Non Invasive Prenatal Testing (NIPT) Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
The major players in the market are as follows:
1. Ge Healthcare (A Wholly Owned Subsidiary of General Electric Company)
2. Koninklijke Philips N.V.
3. Illumina, Inc.
4. Thermo Fisher Scientific, Inc.
5. F. Hoffman-La Roche Ltd.
6. Pacific Biosciences of California, Inc.
7. Perkinelmer, Inc.
8. Qiagen N.V.
9. Agilent Technologies, Inc.
10. Beijing Genomics Institute
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the Non Invasive Prenatal Testing (NIPT)Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
Access Full Report Here – https://www.kennethresearch.com/report-details/global-non-invasive-prenatal-testing-nipt-market/10059405
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
Name: Kenneth research
Phone: +1 313 462 0609
Mason Mount is is an energetic and versatile freelance writer for 5 years, he pens down any type of article and web content. He is a Cambridge University Business English Certificate (Europe Level) holder. He is analytical, enthusiastic, and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses.